Durham College (DC) and Emblem Corp. (TSXV:EMC) (EMC.WT) (Emblem), on behalf of its health and education subsidiary GrowWise Health Limited (GrowWise), are partnering to develop and launch the Cannabis Industry Specialization certificate in fall 2018. The first of its kind in Ontario, the part-time studies program will be delivered both in class and online via simulcast. It is designed to prepare professionals with business experience or who have already completed a diploma or degree in business to pursue a career in the rapidly growing cannabis sector.

“The long-term success of Canada’s cannabis industry will depend strongly on there being a skilled workforce to support and advance it,” said Adam Saperia, president, GrowWise. “Together, GrowWise and Durham College are ensuring that the right education and training are available to those who are interested in entering this exciting field.”


Other industry leaders are joining GrowWise in contributing expertise to the development of the program’s curriculum, including Ample Organics, Cannabis at Work, Molecular Science Corp., and CannaInvestor Magazine. Building on the success of the college’s Medical Cannabis Fundamentals for Business Professionals course, the new certificate will include a course focused on medical cannabis fundamentals and expand the scope of students’ learning with courses focused on areas such as cannabis in the recreational/adult-use market, cannabis regulatory affairs and ethics, importing and exporting cannabis and cannabis business operations. Students who have already successfully completed DC’s two-day, introductory medical cannabis course will be eligible to receive academic credit towards earning their certificate.

“With Canada already established as a global leader in medical cannabis and soon to become only the second country in the world to legalize adult recreational use on a national level, the need for skilled business professionals will continue to grow dramatically,” said Debbie Johnston, dean of DC’s School of Continuing Education, which will deliver the program. “While other programs focus on the production side of the industry, Durham College is leading the way in preparing professionals interested in management and non-horticultural roles. Graduates of the Cannabis Industry Specialization certificate will make it easier for employers to recognize the right candidates for their jobs.”

The new program marks the latest development in DC’s work with GrowWise to establish the college as a leader in cannabis-related post-secondary education. The Medical Cannabis Fundamentals for Business Professionals course launched in November 2017 and is now offered on a monthly basis through in-class and interactive simulcast delivery.

About Durham College

At Durham College (DC), the student experience comes first. With campuses in Oshawa and Whitby and a learning site in Pickering, the college offers more than 12,000 full-time post-secondary and apprenticeship students access to more than 140 full-time and eight apprenticeship programs in a number of different disciplines, enabling them to develop the skills required to meet the demands of today’s job market. The college is also set to launch its first four-year degree program, the Honours Bachelor of Health Care Technology Management, in September 2018.

The Oshawa campus features the state-of-the art Student Services building and will soon feature the Centre for Collaborative Education, a legacy project tied to DC’s 50th anniversary in 2017. The new facility will bring together local, Indigenous and global communities, providing a new home for several of the college’s most innovative and ground-breaking programs.

The Whitby campus features the award-winning W. Galen Weston Centre for Food, which includes Bistro ’67, a full-service, teaching-inspired restaurant, and Pantry, a retail store featuring food prepared by students in the college’s culinary programs.

For more information, visit www.durhamcollege.ca or call 905.721.2000.

About GrowWise Health

GrowWise Health, a subsidiary of Emblem Corp., provides patients and healthcare providers with personalized education to make informed choices about medical cannabis treatments. With education centres across Ontario and British Columbia, prospective patients can learn more at www.growwisehealth.com.

About Emblem

Emblem Corp., through its wholly-owned subsidiary Emblem Cannabis Corporation, is a fully integrated licensed producer and distributor of medical cannabis and cannabis derivatives in Canada under the ACMPR (Access to Cannabis for Medical Purposes Regulations). Led by a team of cannabis experts and former health care and pharma executives, it has three distinct verticals – cannabis production, patient education centers, and pharmaceutical dosage form development. Emblem trades under the ticker symbol EMC on the TSX Venture Exchange.

For further information contact:

Melissa McLean Ethan Karayannopoulos
Communications and Marketing Investor Relations
Durham College Emblem Corp.
905.721.2000 ext. 2952 647.748.9696
melissa.mclean@durhamcollege.ca ethank@emblemcorp.com 

Forward-looking statements

This press release contains certain forward-looking information and forward-looking statements within the meaning of applicable Canadian securities laws (collectively, “forward-looking statements”). Forward-looking statements are often, but not always, identified by the use of words such as “anticipate”, “believe”, “plan”, “potential”, “intend”, “may”, “will”, “should”, or similar words suggesting future outcomes. Forward-looking statements are subject to certain risks and uncertainties that could cause actual events or outcomes to differ materially from those anticipated or implied by such forward-looking statements. These factors include changes in market and competition, governmental or regulatory developments and general economic conditions. The forward-looking statements contained in this document are made as at the date of this news release and Emblem does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by applicable securities laws.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Source: globenewswire.com

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”), of the important December 1, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Aurora investors under the federal securities laws.

To join the Aurora class action, go to http://www.rosenlegal.com/cases-register-1965.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

Keep reading... Show less

Trading resumes in:

Company: 4Front Ventures Corp.

Keep reading... Show less

/NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES /

  4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) (” 4Front ” or the ” Company “) is pleased to announce that it has completed its previously announced bought deal prospectus offering (the ” Offering “) of units of the Company (” Units “), for aggregate gross proceeds of C$17,251,150 including full exercise of the over-allotment option granted to the underwriters in connection therewith.

Keep reading... Show less

Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss, you can request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. A lead plaintiff acts on behalf of all other class members in directing the litigation. The lead plaintiff can select a law firm of its choice. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff

Tactile Systems Technology (NASDAQ:TCMD)
Class Period:
May 7, 2018 – June 8, 2020
Deadline: November 30, 2020
For more info: www.bgandg.com/tcmd

Keep reading... Show less

Khiron Life Sciences Corp. (“ Khiron ” or, the “ Company ”) (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), announced today that it has re-filed its unaudited condensed interim consolidated financial statements, together with the notes thereto, for the three and six months ended June 30, 2020 and 2019 (the “ Interim Financial Statements ”) to correct, among other things, certain 2019 comparative period information and to update certain presentation arising from the Company’s early adoption of IFRS 3 in late 2019, which changes were identified in connection with the Company’s review engagement with its auditor. The Company does not consider these adjustments either individually nor in the aggregate, to be material.

The re-filed Interim Financial Statements reflect changes to the Condensed Interim Consolidated Statements of Loss and Comprehensive Loss comparative period to remove transaction fees from the income statement and capitalize them to the applicable acquisition in accordance with the Company’s early adoption of the amended IFRS 3 as set out in Note 2, and to reclassify $1 million from general and administrative expenses to transaction fees for presentation purposes to conform with the Company’s presentation used in its audited consolidated financial statements for the years ended December 31, 2019 and 2018 (the “ Audited Annual Financial Statements ”). The re-filed interim Financial Statements also reflect changes to the Condensed Interim Consolidated Statement of Changes in Shareholders’ Equity to correct the 2019 comparative period balances as they incorrectly reflect Q1 2019 period balances, update certain presentation to conform with the Company’s presentation used in its Audited Annual Financial Statements; and reduce the valuation conclusion of the Company’s acquisition of NettaGrowth International Inc. to conform with the Audited Annual Financial Statements. The re-filed Interim Financial Statements also bring forward the subsequent event note disclosure.

Keep reading... Show less